{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T13:26:06Z","timestamp":1783776366361,"version":"3.55.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1111147"],"award-info":[{"award-number":["OPP1111147"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1003203","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T17:24:27Z","timestamp":1598030667000},"page":"e1003203","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1479-8773","authenticated-orcid":true,"given":"Rebecca E.","family":"Watts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Odedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Marquart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lachlan","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azrin N.","family":"Abd-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cascales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9306-1851","authenticated-orcid":true,"given":"Stephan","family":"Chalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2715-7182","authenticated-orcid":true,"given":"Maria","family":"Rebelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4802-0647","authenticated-orcid":true,"given":"Zuleima","family":"Pava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7080-2215","authenticated-orcid":true,"given":"Katharine A.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cielo","family":"Pasay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Peatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-9649","authenticated-orcid":true,"given":"J\u00f6rg J.","family":"M\u00f6hrle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6596-9718","authenticated-orcid":true,"given":"James S.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,8,21]]},"reference":[{"key":"pmed.1003203.ref001","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"EA Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"pmed.1003203.ref002","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"AM Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"pmed.1003203.ref003","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"F Ariey","year":"2014","journal-title":"Nature"},{"key":"pmed.1003203.ref004","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"J Straimer","year":"2015","journal-title":"Science"},{"key":"pmed.1003203.ref005","doi-asserted-by":"crossref","first-page":"e00479","DOI":"10.1128\/IAI.00479-17","article-title":"Controlled human malaria infection: applications, advances, and challenges","volume":"86","author":"DI Stanisic","year":"2018","journal-title":"Infect Immun"},{"key":"pmed.1003203.ref006","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1093\/jac\/dkw174","article-title":"Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers","volume":"71","author":"JS McCarthy","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"pmed.1003203.ref007","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1473-3099(17)30171-8","article-title":"Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a\/1b randomised study","volume":"17","author":"JS McCarthy","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"pmed.1003203.ref008","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s12936-016-1511-3","article-title":"A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study","volume":"15","author":"JS McCarthy","year":"2016","journal-title":"Malar J"},{"key":"pmed.1003203.ref009","doi-asserted-by":"crossref","first-page":"e21914","DOI":"10.1371\/journal.pone.0021914","article-title":"A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs","volume":"6","author":"JS McCarthy","year":"2011","journal-title":"PLoS ONE"},{"key":"pmed.1003203.ref010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12936-018-2435-x","article-title":"A bioreactor system for the manufacture of a genetically modified Plasmodium falciparum blood stage malaria cell bank for use in a clinical trial","volume":"17","author":"R Pawliw","year":"2018","journal-title":"Malar J"},{"key":"pmed.1003203.ref011","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1475-2875-10-48","article-title":"A real-time, quantitative PCR method using hydrolysis probes for the monitoring of Plasmodium falciparum load in experimentally infected human volunteers","volume":"10","author":"RJ Rockett","year":"2011","journal-title":"Malar J"},{"key":"pmed.1003203.ref012","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI98012","article-title":"A controlled human malaria infection model enabling evaluation of transmission-blocking interventions","volume":"128","author":"KA Collins","year":"2018","journal-title":"J Clin Invest"},{"key":"pmed.1003203.ref013","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1128\/AAC.04942-14","article-title":"Evaluating the pharmacodynamic effect of antimalarial drugs in clinical trials by quantitative PCR","volume":"59","author":"L Marquart","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"pmed.1003203.ref014","first-page":"279","volume-title":"The Handbook of Research Synthesis and Meta-Analysis","author":"S Konstantopoulos","year":"2009","edition":"2"},{"key":"pmed.1003203.ref015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1017\/S0031182001001202","article-title":"Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection","volume":"124","author":"JA Simpson","year":"2002","journal-title":"Parasitology"},{"key":"pmed.1003203.ref016","first-page":"963","article-title":"Growth rate of Plasmodium falciparum: analysis of parasite growth data from malaria volunteer infection studies","volume":"221","author":"LF Wockner","year":"2020","journal-title":"J Infect Dis"},{"key":"pmed.1003203.ref017","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1473-3099(12)70181-0","article-title":"Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study","volume":"12","author":"C Amaratunga","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"pmed.1003203.ref018","doi-asserted-by":"crossref","first-page":"12513","DOI":"10.1073\/pnas.1813386115","article-title":"Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model","volume":"115","author":"JM S\u00e1","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pmed.1003203.ref019","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.1128\/AAC.00481-15","article-title":"How robust are malaria parasite clearance rates as indicators of drug effectiveness and resistance?","volume":"59","author":"IM Hastings","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"pmed.1003203.ref020","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4269\/ajtmh.2001.65.690","article-title":"Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy?","volume":"65","author":"PT Giao","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"pmed.1003203.ref021","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijpddr.2012.01.001","article-title":"Artemisinin resistance in Plasmodium falciparum: a process linked to dormancy?","volume":"2","author":"Q Cheng","year":"2012","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"pmed.1003203.ref022","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/656476","article-title":"Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure","volume":"202","author":"F Teuscher","year":"2010","journal-title":"J Infect Dis"},{"key":"pmed.1003203.ref023","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ebiom.2018.09.018","article-title":"Liver injury in uncomplicated malaria is an overlooked phenomenon: an observational study","volume":"36","author":"IJ Reuling","year":"2018","journal-title":"EBioMedicine"},{"key":"pmed.1003203.ref024","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0140-6736(18)30291-5","article-title":"Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b\/4 trial","volume":"391","author":"The West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)","year":"2018","journal-title":"Lancet"},{"key":"pmed.1003203.ref025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4269\/ajtmh.17-0754","article-title":"The dynamics of liver function test abnormalities after malaria infection: a retrospective observational study","volume":"98","author":"J Woodford","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"pmed.1003203.ref026","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/1475-2875-8-277","article-title":"Cardiac complication after experimental human malaria infection: a case report","volume":"8","author":"AE Nieman","year":"2009","journal-title":"Malar J"},{"key":"pmed.1003203.ref027","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1475-2875-13-38","article-title":"Idiopathic acute myocarditis during treatment for controlled human malaria infection: a case report","volume":"13","author":"MP van Meer","year":"2014","journal-title":"Malar J"},{"key":"pmed.1003203.ref028","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/jcph.679","article-title":"Arrhythmias seen in baseline 24-hour Holter ECG recordings in healthy normal volunteers during Phase 1 clinical trials","volume":"56","author":"P Hingorani","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"pmed.1003203.ref029","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2125.1995.tb05724.x","article-title":"Use of 24 h ambulatory ECG recordings in the assessment of new chemical entities in healthy volunteers","volume":"39","author":"JC Stinson","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"pmed.1003203.ref030","doi-asserted-by":"crossref","first-page":"e02141","DOI":"10.1128\/AAC.02141-17","article-title":"Emergence and spread of kelch13 mutations associated with artemisinin resistance in Plasmodium falciparum parasites in 12 Thai Provinces from 2007 to 2016","volume":"62","author":"T Kobasa","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"pmed.1003203.ref031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-018-1207-3","article-title":"Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments\u2014a WWARN individual patient data meta-analysis","volume":"17","author":"WWARN K13 Genotype-Phenotype Study Group","year":"2019","journal-title":"BMC Med"},{"key":"pmed.1003203.ref032","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","article-title":"A worldwide map of Plasmodium falciparum K13-propeller polymorphisms","volume":"374","author":"D Menard","year":"2016","journal-title":"N Engl J Med"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T10:02:04Z","timestamp":1667988124000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003203"}},"subtitle":[],"editor":[{"given":"Lorenz","family":"von Seidlein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,21]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003203","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,21]]}}}